Insights - Bristol Myers Squibb announced the acquisition of Karuna (KRTX) for $14B to add a first-in-class schizophrenia drug and neuroscience pipeline. You can read more about … Continue Reading
Read nowInsights - Yesterday, both obesity and radiopharmaceuticals had year end catalysts that unfortunately did not meet investor expectations. Structure (GPCR) Weight Loss UpdateGPCR traded down 42% on … Continue Reading
Read nowInsights - Mural Oncology (MURA) is a recent spinout from Alkermes’ (ALKS) oncology division. MURA trades at a 78% discount to its cash balance. Yes, you read … Continue Reading
PremiumInterviews - PropThink interviewed Jordan Plews, PhD. co-Founder and CEO of Elevai Labs. Dr. Plews completed his postdoctoral and business school training at Stanford University after completing … Continue Reading
Read nowInsights - Medtronic called off its plans to buy EOFlow, a company making an insulin patch-pump that is embroiled in a patent dispute with Insulet (PODD). In May 2023, … Continue Reading
PremiumResearch - The big news in obesity last week was that Pfizer’s Phase 2b data for twice-oral danuglipron flopped. Pfizer’s drug had high discontinuation as a result of high … Continue Reading
Read nowInterviews - TRANSCRIPTParticipants Amelia Tower, KOL Adrian Mendes, Perimeter Medical CEO Deniel Mero, PropThink Editor PropThink Good afternoon everyone, welcome to PropThink’s Digital Conference. My name is … Continue Reading
Read now
